Form 4 for STLN Starling Oncology, Inc.
Accepted 2025-08-21 00:00:00 ET · period of report 2025-08-19 · accession 0000935836-25-000552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-21 | 2025-08-19 | STLN | Hively Brad | Dir | S - Sale | $4.06 | -20.2K | 623.0K | -3% | -$82.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-08-19 | S | D | 20,221 | $4.06 | 622,980 | D | — | — |